The emerging antimicrobial resistance crisis during the COVID-19 surge in China.

Wang, Zhicheng; Yu, Mengke; Lin, Leesa

Wang, Zhicheng; Yu, Mengke; Lin, Leesa.

Wang Z; China Development Research Foundation, Beijing 100009, China. Electronic address: wangzc61@gmail.com.
Yu M; China Development Research Foundation, Beijing 100009, China.
Lin L; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK; Laboratory of Data Discovery for Health, Hong Kong Special Administrative Region, China. Electronic address: leesa.lin@lshtm.ac.uk.

Lancet Microbe ; 4(5): e290-e291, 2023 05.

Article in English | MEDLINE | ID: covidwho-2236863

Subject(s)

COVID-19; Humans; Anti-Bacterial Agents/pharmacology; Anti-Bacterial Agents/therapeutic use; Drug Resistance, Bacterial; SARS-CoV-2; Surge Capacity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Lancet Microbe Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google